# OnCo record toceranib (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/toceranib/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "toceranib" ;
  schema:name "Toceranib phosphate"@en ;
  schema:alternateName "Palladia"@en, "toceranib"@en, "SU11654"@en, "Palladia" ;
  schema:description "Toceranib (Palladia) is a tablet for dogs, not people, approved by the US Food and Drug Administration in 2009 to treat mast cell tumours of the skin that have come back. It blocks the same family of growth signals as the human cancer drug sunitinib."@en ;
  schema:url <https://onco.cc/drugs/toceranib/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.fda.gov/consumers/consumer-updates/my-dog-has-cancer-what-do-i-need-know>, <https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/860>, <https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/888>, <https://doi.org/10.1158/1078-0432.ccr-08-1860> ;
  onco:tag "veterinary", "comparative-oncology" ;
  onco:modality "small molecule (kinase inhibitor)" ;
  onco:related <https://onco.cc/ideas/idea-bio1-comparative-oncology-dogs/>, <https://onco.cc/journals/veterinary-and-comparative-oncology/>, <https://onco.cc/drugs/sunitinib/> ;
  onco:targets <https://onco.cc/targets/kit/>, <https://onco.cc/targets/vegf/>, <https://onco.cc/targets/pdgfrb/> ;
  onco:companies <https://onco.cc/companies/pfizer/> .